Press releases | Finanzwire

Basculer en Français

9715	Companies
193814	Keywords
125022	Articles
103149	Press releases

Home
Press releases

PRESS RELEASE

published on 03/27/2025 at 18:00, 9 months 25 days ago

Following decisive advances and a significant improvement in its results in 2024, Amoéba is approaching 2025 with confidence and is getting closer to commercialising its first products
Amoéba achieves significant milestones in 2024, including strategic partnerships, financial improvements, and advancements in biocontrol and cosmetics. Financial statements show positive growth

AMOEBA Financial Statements Partnerships Biocontrol Cosmetics
PRESS RELEASE

published on 03/27/2025 at 18:00, 9 months 25 days ago

Continued profitable growth and strong cash generation at the end of fiscal 2024
EPC Groupe's FY 2024 results: Sales up 3.2%, EBITDA up 2.1%, free cash flow €40.0M. Proposed dividend of 1.50 € per share

Financial Results EBITDA Dividend EPC Groupe FY 2024
PRESS RELEASE

published on 03/27/2025 at 18:00, 9 months 25 days ago

FIRST-HALF 2024/25 RESULTS
Eagle Football Group's Board of Directors approves the 2024/2025 interim financial statements reflecting revenues from business activities, player trading, and cost-cutting measures

Financial Statements Revenue Cost-cutting Player Trading Eagle Football Group
PRESS RELEASE

published on 03/27/2025 at 18:00, 9 months 25 days ago

Oxurion Receives Amended Transparency Notification from Atlas Special Opportunities II LLC
Oxurion NV received an amended transparency notification from Atlas Special Opportunities II, LLC regarding the sale of voting securities. This press release replaces the one from March 18, 2025

Transparency Notification Euronext Brussels Oxurion NV Retinal Disease Therapies Atlas Special Opportunities II
PRESS RELEASE

published on 03/27/2025 at 17:47, 9 months 25 days ago

Funding Circle Plc: POS-Transaction in Own Shares
Funding Circle Plc purchases 243,065 Ordinary Shares for cancellation. Highest price: 120.00p, Lowest price: 117.00p. Company's issued share capital: 317,798,217 shares

London Stock Exchange Ordinary Shares Share Buyback Programme Funding Circle Plc Investec Bank
PRESS RELEASE

published on 03/27/2025 at 17:45, 9 months 25 days ago

SAF-HOLLAND sets new medium-term targets with the 'drive2030' corporate strategy – Group sales expected to increase by more than 50% to over EUR 3,000 million
SAF-HOLLAND presents 'drive2030' strategy at Capital Markets Day, targeting over €3bn in sales & 10-12% EBIT margin by 2030. Focus on growth, efficiency, and sustainability

Sales Growth Strategy Capital Markets Day SAF-HOLLAND Drive2030
PRESS RELEASE

published on 03/27/2025 at 17:45, 9 months 25 days ago

DKSH’s 92nd Annual General Meeting 2025
DKSH's 92nd Annual General Meeting 2025: Shareholders approve dividend increase to CHF 2.35 per share. Reelection of Board members and new appointment. Total of 166 shareholders present

Annual General Meeting Shareholders Dividend Increase DKSH Réélection
PRESS RELEASE

published on 03/27/2025 at 17:45, 9 months 25 days ago

2024 Annual Results: Strong Growth and Exceptional Improvement Across All Profitability Indicators
STIF (FR001400MDW2, ALSTI) reports strong growth and exceptional improvement in all profitability indicators in 2024. Revenue up by 72.7% driven by BESS activity. Plans for further growth, product diversification, and geographical expansion in 2025

Revenue Growth Geographical Expansion STIF BESS 2024 Financial Results
PRESS RELEASE

published on 03/27/2025 at 17:45, 9 months 25 days ago

Inside Information / Other news releases
Verallia releases its 2024 Universal Registration Document filing with the AMF in ESEF format. Document accessible on Verallia's and AMF's websites, containing financial and governance reports as well as sustainability information

Sustainability AMF ESEF Format Verallia 2024 Universal Registration Document
PRESS RELEASE

published on 03/27/2025 at 17:45, 9 months 25 days ago

Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ? Strong Outlook for 2025
Transgene achieves key milestones in 2024, including clinical proof of principle for individualized cancer vaccine TG4050, with strong outlook for 2025. New trial planned in Q4 2025 for a second indication

Milestones Cancer Vaccine Transgene 2025 Outlook Clinical Proof

Accesswire

Published on 01/22/2026 at 00:00, 3 hours 31 minutes ago

Onco-Innovations Engages i2i Marketing Group Engagement for Market Awareness Services
Published on 01/22/2026 at 00:00, 3 hours 31 minutes ago

TDG Gold Corp. Grants Stock Options
Published on 01/22/2026 at 00:00, 3 hours 31 minutes ago

FutureGen Industries Provides Shareholder Update on Expanded Investment Strategy in High-Growth Technology Sectors
Published on 01/21/2026 at 23:30, 4 hours 1 minute ago

Galway Metals Reports Robust PEA Results with 33% and 61% After Tax IRR, Using both Long Term and Spot Pricing Scenarios, Respectively
Published on 01/21/2026 at 22:45, 4 hours 46 minutes ago

Premier American Uranium Announces Bought Deal Private Placement for Gross Proceeds of C$10 Million

View all ACCESSWIRE

EQS Group

Published on 01/22/2026 at 01:33, 1 hour 57 minutes ago

EQS-Adhoc: ADTRAN Holdings, Inc.: Preliminary revenue above guidance and non-GAAP earnings per share above analyst consensus for Q4 2025
Published on 01/21/2026 at 22:11, 5 hours 19 minutes ago

SNP Remains on Growth Trajectory in 2025 with Third Consecutive Record Year
Published on 01/21/2026 at 21:09, 6 hours 21 minutes ago

EQS-Adhoc: Deutsche Börse AG: Deutsche Börse AG and Allfunds Group plc reached an agreement on recommended acquisition by Deutsche Börse AG of Allfunds Group plc
Published on 01/21/2026 at 17:47, 9 hours 43 minutes ago

CPI PROPERTY GROUP – Sustainable Finance Update
Published on 01/21/2026 at 16:51, 10 hours 39 minutes ago

EQS-Adhoc: SNP SE: Revenue and EBIT in Fiscal Year 2025 Better Than Expected

Les Echos

Published on 01/21/2026 at 17:40, 9 hours 51 minutes ago

Eiffage wins in consortium the contract to replace the steel bridge over the Kiel Canal in Germany
Published on 01/21/2026 at 08:45, 18 hours 46 minutes ago

ENGIE signs a 10-year Biomethane Purchase Agreement with PepsiCo, its first in the United Kingdom
Published on 01/20/2026 at 17:59, 1 day 9 hours ago

Statement of transactions in own shares from January 14, 2026 to January 16, 2026
Published on 01/20/2026 at 17:45, 1 day 9 hours ago

Change in Baikowski® executive management
Published on 01/20/2026 at 07:30, 1 day 20 hours ago

Gimv leads € 51 million Series B investment round in Exciva to advance innovative Alzheimer’s therapy

View all LES ECHOS COMFI WIRE